• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Patent and Exclusivity Search Results from query on Appl No 021437 Product 002 in the OB_Rx list.


Patent Data

Appl No Prod No Patent No Patent
Expiration
Drug Substance
Claim
Drug Product
Claim
Patent Use
Code
Delist
Requested
N021437 002 6410054 Dec 8, 2019 U - 537
N021437 002 6410054 Dec 8, 2019 U - 3
N021437 002 6410054*PED Jun 8, 2020
N021437 002 6410524 Nov 5, 2019 U - 467
N021437 002 6410524*PED May 5, 2020
N021437 002 6495165 Dec 8, 2019 U - 537
N021437 002 6495165 Dec 8, 2019 U - 3
N021437 002 6495165*PED Jun 8, 2020
N021437 002 6534093 Dec 8, 2019 U - 537
N021437 002 6534093 Dec 8, 2019 U - 3
N021437 002 6534093*PED Jun 8, 2020
N021437 002 6558707 Dec 8, 2019 Y U - 537
N021437 002 6558707*PED Jun 8, 2020
N021437 002 6747020 Nov 5, 2019 U - 587
N021437 002 6747020*PED May 5, 2020
N021437 002 7157101 Dec 8, 2019 Y U - 664
N021437 002 7157101*PED Jun 8, 2020

Exclusivity Data

There is no unexpired exclusivity for this product.


Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.


View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through September 2014
Patent and Generic Drug Product Data Last Updated October 30, 2014

-
-